Australia News
-
Australia's Propanc Biopharma gets US Patent
Australia | News | 0 Comment | 23 Aug, 2019
Melbourne based Propanc Biopharma Inc., a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, has announced that it has r...Read more
-
Q-Sera’s Blood Clotting Technology Granted Patent in US
Australia | News | 0 Comment | 21 Aug, 2019
Australia based Medical device company Q-Sera Pty Ltd has announced that it has received a Notice of Allowance from the United States Patent & Trademark Office for the foundation patent...Read more
-
GE Healthcare partnership takes aim at Brain Aneurysms with AI
Australia | News | 0 Comment | 13 Aug, 2019
GE Healthcare, Fujitsu Australia, Macquarie University and Macquarie Medical Imaging has announced a new research collaboration to diagnose and monitor brain aneurysms on scans faster and m...Read more
-
The iQ Group Global stands among 5 most Innovative companies 2019
Australia | News | 0 Comment | 12 Aug, 2019
The iQ Group Global is honoured to be recognised as one of Australia and New Zealand's Top 5 Most Innovative Companies by The Australian Financial Review ...Read more
-
ANDHealth joins leading institutes to drive digital healthcare
Australia | News | 0 Comment | 09 Aug, 2019
Leading medical research institutes and universities in Western Australia have announced a new partnership with ANDHealth, as part of the State’s first Digital Health Accelerator Prog...Read more
-
Global Diagnostics Australia Incorporates AI into Radiology Applications
Australia | News | 0 Comment | 08 Aug, 2019
Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has announced that it has adopted artificial intelligence (AI) applications into its radiology work...Read more
-
SpeeDx secures $15M from US investment partnership
Australia | News | 0 Comment | 07 Aug, 2019
SpeeDx Pty. Ltd., an Australia based developer of disruptive new molecular diagnostic solutions has announced that it has raised funds from US-based Northpond Ventures in its additional equ...Read more
-
TGA approves new drug for diabetes induced vision loss
Australia | News | 0 Comment | 06 Aug, 2019
Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with long-lasting effect. The Therapeutic Good...Read more
-
Chemist Warehouse to provide affordable orthodontic clear aligner therapy
Australia | News | 1 Comment | 05 Aug, 2019
Chemist Warehouse, on 5 August 2019, announced its partnership with SmileDirectClub, the US-based teledentistry pioneer, to expand access to affordable&nb...Read more
-
Botanix receives commitments for A$40M in US-led institutional placement
Australia | News | 0 Comment | 05 Aug, 2019
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm commitments in respect of a A$40m placement led by specialist US-based b...Read more
-
Biocon, Mylan launch Ogivri in Australia
Australia | News | 0 Comment | 02 Aug, 2019
Biocon Ltd. and Mylan N.V. have announced the launch in Australia of Ogivri™ (trastuzumab), a biosimilar to Herceptin®1 (trastuzumab), for the treatment of HER2-ove...Read more
-
Alterity Therapeutics announces successful completion of Phase 1 Clinical Trial
Australia | News | 0 Comment | 31 Jul, 2019
Alterity Therapeutics Limited has announced that it has successfully completed its Phase 1 study of PBT434, a novel, orally bioavailable small molecule inhibitor of alpha- synuclein aggrega...Read more
-
NanoCellect Biomedical expands distribution to Australia, NZ
Australia | News | 0 Comment | 25 Jul, 2019
US headquartered NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, has announced an exclusive agreement ...Read more
-
Kazia to use drug with radiotherapy for brain cancer treatment
Australia | News | 0 Comment | 23 Jul, 2019
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) in New York, NY will inv...Read more
-
Kazia Therapeutics calls for greater awareness of brain cancer in the US
Australia | News | 0 Comment | 18 Jul, 2019
This Glioblastoma Awareness Day, on 17th July 2019, Australian oncology-focused biotech company, Kazia Therapeutics Ltd, calls for greater awareness of the most lethal brain cancer in ...Read more
-
Servier Australia, BioCurate to accelerate drug discovery
Australia | News | 0 Comment | 17 Jul, 2019
Servier Australia and BioCurate have struck an agreement to share commercial and scientific expertise with the aim of accelerating the discovery of new therapeutics and drugs. Servier and ...Read more
-
BI announces Dabigatran's safety and efficacy for management of VTE in children
Australia | News | 0 Comment | 09 Jul, 2019
Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019...Read more
-
ISTH launches education initiative in gene therapy for hemophilia
Australia | News | 0 Comment | 08 Jul, 2019
The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch of Gene Therapy in Hemophilia: An ISTH Education Initiative. This la...Read more
